Tryptophan breakdown pathway in bipolar mania

Aye Mu Myint, Yong Ku Kim, Robert Verkerk, Sun-Hwa Park, Simon Scharpé, Harry W M Steinbusch, Brian E. Leonard

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The upregulation of the initiating step of the kynurenine pathway was demonstrated in postmortem anterior cingulated cortex from individuals with schizophrenia and bipolar disorder. However, the tryptophan and kynurenine metabolism in bipolar mania patients especially in drug naïve state has not been clearly explored. This study explored the plasma tryptophan and its competing amino acids, kynurenine, kynurenic acid and 3-hydroxyanthranillic acid and their association with psychopathological scores in 39 drug naïve and drug-free bipolar manic patients in comparison with 80 healthy controls. When age and gender were controlled in multivariate analysis, bipolar manic patients have significantly lower tryptophan index than normal controls (f = 9.779, p = 0.004). The mean plasma tryptophan concentration and mean tryptophan index were reduced and mean tryptophan breakdown index was increased significantly after a 6-week treatment. The reduction in plasma tryptophan and reduction in tryptophan index showed significant negative correlation with reduction in YMRS score (r = - 0.577, p = 0.019 and r = - 0.520, p = 0.039 respectively). The reduction in YMRS also showed positive correlation with both plasma tryptophan concentration and tryptophan index both at the time of admission (r = 0.464, p = 0.019 and r = 0.4, p = 0.047 respectively) and discharged (r = 0.529, p = 0.035 and r = 0.607, p = 0.013 respectively). The reduction in BPRS score also showed positive correlation with tryptophan index at the time of discharge (r = 0.406, p = 0.044). These findings indicated the involvement of bi-directional tryptophan metabolism and kynurenine pathway in pathophysiology and response to medication in bipolar mania.

Original languageEnglish
Pages (from-to)65-72
Number of pages8
JournalJournal of Affective Disorders
Volume102
Issue number1-3
DOIs
Publication statusPublished - 2007 Sep 1
Externally publishedYes

Fingerprint

Bipolar Disorder
Tryptophan
Kynurenine
Pharmaceutical Preparations
Kynurenic Acid
Schizophrenia
Up-Regulation
Multivariate Analysis
Amino Acids
Acids

Keywords

  • Bipolar mania
  • Kynurenine
  • Tryptophan

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Myint, A. M., Kim, Y. K., Verkerk, R., Park, S-H., Scharpé, S., Steinbusch, H. W. M., & Leonard, B. E. (2007). Tryptophan breakdown pathway in bipolar mania. Journal of Affective Disorders, 102(1-3), 65-72. https://doi.org/10.1016/j.jad.2006.12.008

Tryptophan breakdown pathway in bipolar mania. / Myint, Aye Mu; Kim, Yong Ku; Verkerk, Robert; Park, Sun-Hwa; Scharpé, Simon; Steinbusch, Harry W M; Leonard, Brian E.

In: Journal of Affective Disorders, Vol. 102, No. 1-3, 01.09.2007, p. 65-72.

Research output: Contribution to journalArticle

Myint, AM, Kim, YK, Verkerk, R, Park, S-H, Scharpé, S, Steinbusch, HWM & Leonard, BE 2007, 'Tryptophan breakdown pathway in bipolar mania', Journal of Affective Disorders, vol. 102, no. 1-3, pp. 65-72. https://doi.org/10.1016/j.jad.2006.12.008
Myint, Aye Mu ; Kim, Yong Ku ; Verkerk, Robert ; Park, Sun-Hwa ; Scharpé, Simon ; Steinbusch, Harry W M ; Leonard, Brian E. / Tryptophan breakdown pathway in bipolar mania. In: Journal of Affective Disorders. 2007 ; Vol. 102, No. 1-3. pp. 65-72.
@article{ce47d651f9d0452193f17935e6688f33,
title = "Tryptophan breakdown pathway in bipolar mania",
abstract = "The upregulation of the initiating step of the kynurenine pathway was demonstrated in postmortem anterior cingulated cortex from individuals with schizophrenia and bipolar disorder. However, the tryptophan and kynurenine metabolism in bipolar mania patients especially in drug na{\"i}ve state has not been clearly explored. This study explored the plasma tryptophan and its competing amino acids, kynurenine, kynurenic acid and 3-hydroxyanthranillic acid and their association with psychopathological scores in 39 drug na{\"i}ve and drug-free bipolar manic patients in comparison with 80 healthy controls. When age and gender were controlled in multivariate analysis, bipolar manic patients have significantly lower tryptophan index than normal controls (f = 9.779, p = 0.004). The mean plasma tryptophan concentration and mean tryptophan index were reduced and mean tryptophan breakdown index was increased significantly after a 6-week treatment. The reduction in plasma tryptophan and reduction in tryptophan index showed significant negative correlation with reduction in YMRS score (r = - 0.577, p = 0.019 and r = - 0.520, p = 0.039 respectively). The reduction in YMRS also showed positive correlation with both plasma tryptophan concentration and tryptophan index both at the time of admission (r = 0.464, p = 0.019 and r = 0.4, p = 0.047 respectively) and discharged (r = 0.529, p = 0.035 and r = 0.607, p = 0.013 respectively). The reduction in BPRS score also showed positive correlation with tryptophan index at the time of discharge (r = 0.406, p = 0.044). These findings indicated the involvement of bi-directional tryptophan metabolism and kynurenine pathway in pathophysiology and response to medication in bipolar mania.",
keywords = "Bipolar mania, Kynurenine, Tryptophan",
author = "Myint, {Aye Mu} and Kim, {Yong Ku} and Robert Verkerk and Sun-Hwa Park and Simon Scharp{\'e} and Steinbusch, {Harry W M} and Leonard, {Brian E.}",
year = "2007",
month = "9",
day = "1",
doi = "10.1016/j.jad.2006.12.008",
language = "English",
volume = "102",
pages = "65--72",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Tryptophan breakdown pathway in bipolar mania

AU - Myint, Aye Mu

AU - Kim, Yong Ku

AU - Verkerk, Robert

AU - Park, Sun-Hwa

AU - Scharpé, Simon

AU - Steinbusch, Harry W M

AU - Leonard, Brian E.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - The upregulation of the initiating step of the kynurenine pathway was demonstrated in postmortem anterior cingulated cortex from individuals with schizophrenia and bipolar disorder. However, the tryptophan and kynurenine metabolism in bipolar mania patients especially in drug naïve state has not been clearly explored. This study explored the plasma tryptophan and its competing amino acids, kynurenine, kynurenic acid and 3-hydroxyanthranillic acid and their association with psychopathological scores in 39 drug naïve and drug-free bipolar manic patients in comparison with 80 healthy controls. When age and gender were controlled in multivariate analysis, bipolar manic patients have significantly lower tryptophan index than normal controls (f = 9.779, p = 0.004). The mean plasma tryptophan concentration and mean tryptophan index were reduced and mean tryptophan breakdown index was increased significantly after a 6-week treatment. The reduction in plasma tryptophan and reduction in tryptophan index showed significant negative correlation with reduction in YMRS score (r = - 0.577, p = 0.019 and r = - 0.520, p = 0.039 respectively). The reduction in YMRS also showed positive correlation with both plasma tryptophan concentration and tryptophan index both at the time of admission (r = 0.464, p = 0.019 and r = 0.4, p = 0.047 respectively) and discharged (r = 0.529, p = 0.035 and r = 0.607, p = 0.013 respectively). The reduction in BPRS score also showed positive correlation with tryptophan index at the time of discharge (r = 0.406, p = 0.044). These findings indicated the involvement of bi-directional tryptophan metabolism and kynurenine pathway in pathophysiology and response to medication in bipolar mania.

AB - The upregulation of the initiating step of the kynurenine pathway was demonstrated in postmortem anterior cingulated cortex from individuals with schizophrenia and bipolar disorder. However, the tryptophan and kynurenine metabolism in bipolar mania patients especially in drug naïve state has not been clearly explored. This study explored the plasma tryptophan and its competing amino acids, kynurenine, kynurenic acid and 3-hydroxyanthranillic acid and their association with psychopathological scores in 39 drug naïve and drug-free bipolar manic patients in comparison with 80 healthy controls. When age and gender were controlled in multivariate analysis, bipolar manic patients have significantly lower tryptophan index than normal controls (f = 9.779, p = 0.004). The mean plasma tryptophan concentration and mean tryptophan index were reduced and mean tryptophan breakdown index was increased significantly after a 6-week treatment. The reduction in plasma tryptophan and reduction in tryptophan index showed significant negative correlation with reduction in YMRS score (r = - 0.577, p = 0.019 and r = - 0.520, p = 0.039 respectively). The reduction in YMRS also showed positive correlation with both plasma tryptophan concentration and tryptophan index both at the time of admission (r = 0.464, p = 0.019 and r = 0.4, p = 0.047 respectively) and discharged (r = 0.529, p = 0.035 and r = 0.607, p = 0.013 respectively). The reduction in BPRS score also showed positive correlation with tryptophan index at the time of discharge (r = 0.406, p = 0.044). These findings indicated the involvement of bi-directional tryptophan metabolism and kynurenine pathway in pathophysiology and response to medication in bipolar mania.

KW - Bipolar mania

KW - Kynurenine

KW - Tryptophan

UR - http://www.scopus.com/inward/record.url?scp=34447250001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447250001&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2006.12.008

DO - 10.1016/j.jad.2006.12.008

M3 - Article

C2 - 17270276

AN - SCOPUS:34447250001

VL - 102

SP - 65

EP - 72

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1-3

ER -